 | • レポートコード：MRC2102QY4566 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のデュシェンヌ型筋ジストロフィー市場について種類別（デフラザコート、プレドニゾン、その他）、用途別（男性、女性）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・デュシェンヌ型筋ジストロフィー市場の概要 ・世界の主要地域別デュシェンヌ型筋ジストロフィー市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のデュシェンヌ型筋ジストロフィー市場規模2015-2026：種類別（デフラザコート、プレドニゾン、その他） ・世界のデュシェンヌ型筋ジストロフィー市場規模2015-2026：用途別（男性、女性） ・デュシェンヌ型筋ジストロフィーの米国市場規模2015-2020 ・デュシェンヌ型筋ジストロフィーのヨーロッパ市場規模2015-2020 ・デュシェンヌ型筋ジストロフィーの中国市場規模2015-2020 ・デュシェンヌ型筋ジストロフィーの日本市場規模2015-2020 ・デュシェンヌ型筋ジストロフィーの東南アジア市場規模2015-2020 ・デュシェンヌ型筋ジストロフィーのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・デュシェンヌ型筋ジストロフィーの製造コスト分析 ・販売チャネル、流通業者、顧客 ・デュシェンヌ型筋ジストロフィーの市場動向・機会・課題 ・調査の結論 |
uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys’ respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The classification of duchenne muscular dystrophy includes deflazacort, prednisone and others. And the proportion of deflazacort in 2017 is about 44%.
Market Analysis and Insights: Global Duchenne Muscular Dystrophy Market
The global Duchenne Muscular Dystrophy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Duchenne Muscular Dystrophy Scope and Market Size
The global Duchenne Muscular Dystrophy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Duchenne Muscular Dystrophy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Duchenne Muscular Dystrophy market is segmented into
Deflazacort
Prednisone
Others
Segment by Application, the Duchenne Muscular Dystrophy market is segmented into
Male
Female
The Duchenne Muscular Dystrophy market is analysed and market size information is provided by regions (countries). Segment by Application, the Duchenne Muscular Dystrophy market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Duchenne Muscular Dystrophy Market Share Analysis
Duchenne Muscular Dystrophy market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Duchenne Muscular Dystrophy business, the date to enter into the Duchenne Muscular Dystrophy market, Duchenne Muscular Dystrophy product introduction, recent developments, etc.
The major vendors covered:
PTC Therapeutics
Sarepta Therapeutics
Others
1 Duchenne Muscular Dystrophy Market Overview
1.1 Duchenne Muscular Dystrophy Product Scope
1.2 Duchenne Muscular Dystrophy Segment by Type
1.2.1 Global Duchenne Muscular Dystrophy Sales by Type (2020-2026)
1.2.2 Deflazacort
1.2.3 Prednisone
1.2.4 Others
1.3 Duchenne Muscular Dystrophy Segment by Application
1.3.1 Global Duchenne Muscular Dystrophy Sales Comparison by Application (2020-2026)
1.3.2 Male
1.3.3 Female
1.4 Duchenne Muscular Dystrophy Market Estimates and Forecasts (2015-2026)
1.4.1 Global Duchenne Muscular Dystrophy Sales Growth Rate (2015-2026)
1.4.2 Global Duchenne Muscular Dystrophy Revenue and Growth Rate (2015-2026)
1.4.3 Global Duchenne Muscular Dystrophy Price Trends (2015-2026)
2 Duchenne Muscular Dystrophy Estimate and Forecast by Region
2.1 Global Duchenne Muscular Dystrophy Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Duchenne Muscular Dystrophy Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Duchenne Muscular Dystrophy Sales Market Share by Region (2015-2020)
2.2.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Region (2015-2020)
2.3 Global Duchenne Muscular Dystrophy Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Duchenne Muscular Dystrophy Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Duchenne Muscular Dystrophy Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Duchenne Muscular Dystrophy Estimates and Projections (2015-2026)
2.4.2 Europe Duchenne Muscular Dystrophy Estimates and Projections (2015-2026)
2.4.3 China Duchenne Muscular Dystrophy Estimates and Projections (2015-2026)
2.4.4 Japan Duchenne Muscular Dystrophy Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Duchenne Muscular Dystrophy Estimates and Projections (2015-2026)
2.4.6 India Duchenne Muscular Dystrophy Estimates and Projections (2015-2026)
3 Global Duchenne Muscular Dystrophy Competition Landscape by Players
3.1 Global Top Duchenne Muscular Dystrophy Players by Sales (2015-2020)
3.2 Global Top Duchenne Muscular Dystrophy Players by Revenue (2015-2020)
3.3 Global Duchenne Muscular Dystrophy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Duchenne Muscular Dystrophy as of 2019)
3.4 Global Duchenne Muscular Dystrophy Average Price by Company (2015-2020)
3.5 Manufacturers Duchenne Muscular Dystrophy Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Duchenne Muscular Dystrophy Players (Opinion Leaders)
4 Global Duchenne Muscular Dystrophy Market Size by Type
4.1 Global Duchenne Muscular Dystrophy Historic Market Review by Type (2015-2020)
4.1.1 Global Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
4.1.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2015-2020)
4.1.3 Global Duchenne Muscular Dystrophy Price by Type (2015-2020)
4.2 Global Duchenne Muscular Dystrophy Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Duchenne Muscular Dystrophy Sales Forecast by Type (2021-2026)
4.2.2 Global Duchenne Muscular Dystrophy Revenue Forecast by Type (2021-2026)
4.2.3 Global Duchenne Muscular Dystrophy Price Forecast by Type (2021-2026)
5 Global Duchenne Muscular Dystrophy Market Size by Application
5.1 Global Duchenne Muscular Dystrophy Historic Market Review by Application (2015-2020)
5.1.1 Global Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
5.1.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Application (2015-2020)
5.1.3 Global Duchenne Muscular Dystrophy Price by Application (2015-2020)
5.2 Global Duchenne Muscular Dystrophy Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Duchenne Muscular Dystrophy Sales Forecast by Application (2021-2026)
5.2.2 Global Duchenne Muscular Dystrophy Revenue Forecast by Application (2021-2026)
5.2.3 Global Duchenne Muscular Dystrophy Price Forecast by Application (2021-2026)
6 United States Duchenne Muscular Dystrophy Market Facts & Figures
6.1 United States Duchenne Muscular Dystrophy Sales Market Share by Company (2015-2020)
6.2 United States Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
6.3 United States Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
7 Europe Duchenne Muscular Dystrophy Market Facts & Figures
7.1 Europe Duchenne Muscular Dystrophy Sales Market Share by Company (2015-2020)
7.2 Europe Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
7.3 Europe Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
8 China Duchenne Muscular Dystrophy Market Facts & Figures
8.1 China Duchenne Muscular Dystrophy Sales Market Share by Company (2015-2020)
8.2 China Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
8.3 China Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
9 Japan Duchenne Muscular Dystrophy Market Facts & Figures
9.1 Japan Duchenne Muscular Dystrophy Sales Market Share by Company (3015-3030)
9.2 Japan Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
9.3 Japan Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
10 Southeast Asia Duchenne Muscular Dystrophy Market Facts & Figures
10.1 Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
11 India Duchenne Muscular Dystrophy Market Facts & Figures
11.1 India Duchenne Muscular Dystrophy Sales Market Share by Company (2015-2020)
11.2 India Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
11.3 India Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Duchenne Muscular Dystrophy Business
12.1 PTC Therapeutics
12.1.1 PTC Therapeutics Corporation Information
12.1.2 PTC Therapeutics Business Overview
12.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2015-2020)
12.1.4 PTC Therapeutics Duchenne Muscular Dystrophy Products Offered
12.1.5 PTC Therapeutics Recent Development
12.2 Sarepta Therapeutics
12.2.1 Sarepta Therapeutics Corporation Information
12.2.2 Sarepta Therapeutics Business Overview
12.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sarepta Therapeutics Duchenne Muscular Dystrophy Products Offered
12.2.5 Sarepta Therapeutics Recent Development
12.3 Others
12.3.1 Others Corporation Information
12.3.2 Others Business Overview
12.3.3 Others Duchenne Muscular Dystrophy Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Others Duchenne Muscular Dystrophy Products Offered
12.3.5 Others Recent Development
…
13 Duchenne Muscular Dystrophy Manufacturing Cost Analysis
13.1 Duchenne Muscular Dystrophy Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Duchenne Muscular Dystrophy
13.4 Duchenne Muscular Dystrophy Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Duchenne Muscular Dystrophy Distributors List
14.3 Duchenne Muscular Dystrophy Customers
15 Market Dynamics
15.1 Duchenne Muscular Dystrophy Market Trends
15.2 Duchenne Muscular Dystrophy Opportunities and Drivers
15.3 Duchenne Muscular Dystrophy Market Challenges
15.4 Duchenne Muscular Dystrophy Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Duchenne Muscular Dystrophy Sales (K Doses) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Duchenne Muscular Dystrophy Sales (K Doses) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Duchenne Muscular Dystrophy Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Duchenne Muscular Dystrophy Sales (K Doses) by Region (2015-2020)
Table 5. Global Duchenne Muscular Dystrophy Sales Market Share by Region (2015-2020)
Table 6. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Duchenne Muscular Dystrophy Revenue Share by Region (2015-2020)
Table 8. Global Duchenne Muscular Dystrophy Sales (K Doses) Forecast by Region (2021-2026)
Table 9. Global Duchenne Muscular Dystrophy Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Duchenne Muscular Dystrophy Revenue Share Forecast by Region (2021-2026)
Table 12. Global Duchenne Muscular Dystrophy (K Doses) of Key Companies (2015-2020)
Table 13. Global Duchenne Muscular Dystrophy Sales Share by Company (2015-2020)
Table 14. Global Duchenne Muscular Dystrophy Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Duchenne Muscular Dystrophy Revenue Share by Company (2015-2020)
Table 16. Global Duchenne Muscular Dystrophy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Duchenne Muscular Dystrophy as of 2019)
Table 17. Global Duchenne Muscular Dystrophy Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers Duchenne Muscular Dystrophy Manufacturing Sites and Area Served
Table 19. Manufacturers Duchenne Muscular Dystrophy Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Duchenne Muscular Dystrophy Players
Table 22. Global Duchenne Muscular Dystrophy Sales (K Doses) by Type (2015-2020)
Table 23. Global Duchenne Muscular Dystrophy Sales Share by Type (2015-2020)
Table 24. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Duchenne Muscular Dystrophy Price (K Doses) by Type (2015-2020)
Table 26. Global Duchenne Muscular Dystrophy Sales Share by Type (2021-2026)
Table 27. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Duchenne Muscular Dystrophy Revenue Share by Type (2021-2026)
Table 29. Global Duchenne Muscular Dystrophy Price (K Doses) by Type (2021-2026)
Table 30. Global Duchenne Muscular Dystrophy Sales (K Doses) by Application (2015-2020)
Table 31. Global Duchenne Muscular Dystrophy Sales Share by Application (2015-2020)
Table 32. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Duchenne Muscular Dystrophy Price (K Doses) by Application (2015-2020)
Table 34. Global Duchenne Muscular Dystrophy Sales (K Doses) by Application (2021-2026)
Table 35. Global Duchenne Muscular Dystrophy Sales Share by Application (2021-2026)
Table 36. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Duchenne Muscular Dystrophy Revenue Share by Application (2021-2026)
Table 38. Global Duchenne Muscular Dystrophy Price (K Doses) by Application (2021-2026)
Table 39. United States Duchenne Muscular Dystrophy Sales (K Doses) by Company (2015-2020)
Table 40. United States Duchenne Muscular Dystrophy Sales Market Share by Company (2015-2020)
Table 41. United States Duchenne Muscular Dystrophy Sales (K Doses) by Type (2015-2020)
Table 42. United States Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
Table 43. United States Duchenne Muscular Dystrophy Sales (K Doses) by Application (2015-2020)
Table 44. United States Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
Table 45. Europe Duchenne Muscular Dystrophy Sales (K Doses) by Company (2015-2020)
Table 46. Europe Duchenne Muscular Dystrophy Sales Market Share by Company (2015-2020)
Table 47. Europe Duchenne Muscular Dystrophy Sales (K Doses) by Type (2015-2020)
Table 48. Europe Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
Table 49. Europe Duchenne Muscular Dystrophy Sales (K Doses) by Application (2015-2020)
Table 50. Europe Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
Table 51. China Duchenne Muscular Dystrophy Sales (K Doses) by Company (2015-2020)
Table 52. China Duchenne Muscular Dystrophy Sales Market Share by Company (2015-2020)
Table 53. China Duchenne Muscular Dystrophy Sales (K Doses) by Type (2015-2020)
Table 54. China Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
Table 55. China Duchenne Muscular Dystrophy Sales (K Doses) by Application (2015-2020)
Table 56. China Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
Table 57. Japan Duchenne Muscular Dystrophy Sales (K Doses) by Company (2015-2020)
Table 58. Japan Duchenne Muscular Dystrophy Sales Market Share by Company (2015-2020)
Table 59. Japan Duchenne Muscular Dystrophy Sales (K Doses) by Type (2015-2020)
Table 60. Japan Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
Table 61. Japan Duchenne Muscular Dystrophy Sales (K Doses) by Application (2015-2020)
Table 62. Japan Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Duchenne Muscular Dystrophy Sales (K Doses) by Company (2015-2020)
Table 64. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Duchenne Muscular Dystrophy Sales (K Doses) by Type (2015-2020)
Table 66. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Duchenne Muscular Dystrophy Sales (K Doses) by Type (2015-2020)
Table 68. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
Table 69. India Duchenne Muscular Dystrophy Sales (K Doses) by Company (2015-2020)
Table 70. India Duchenne Muscular Dystrophy Sales Market Share by Company (2015-2020)
Table 71. India Duchenne Muscular Dystrophy Sales (K Doses) by Type (2015-2020)
Table 72. India Duchenne Muscular Dystrophy Sales Market Share by Type (2015-2020)
Table 73. India Duchenne Muscular Dystrophy Sales (K Doses) by Application (2015-2020)
Table 74. India Duchenne Muscular Dystrophy Sales Market Share by Application (2015-2020)
Table 75. PTC Therapeutics Corporation Information
Table 76. PTC Therapeutics Description and Business Overview
Table 77. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. PTC Therapeutics Duchenne Muscular Dystrophy Product
Table 79. PTC Therapeutics Recent Development
Table 80. Sarepta Therapeutics Corporation Information
Table 81. Sarepta Therapeutics Description and Business Overview
Table 82. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Sarepta Therapeutics Duchenne Muscular Dystrophy Product
Table 84. Sarepta Therapeutics Recent Development
Table 85. Others Corporation Information
Table 86. Others Description and Business Overview
Table 87. Others Duchenne Muscular Dystrophy Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Others Duchenne Muscular Dystrophy Product
Table 89. Others Recent Development
Table 90. Production Base and Market Concentration Rate of Raw Material
Table 91. Key Suppliers of Raw Materials
Table 92. Duchenne Muscular Dystrophy Distributors List
Table 93. Duchenne Muscular Dystrophy Customers List
Table 94. Duchenne Muscular Dystrophy Market Key Trends
Table 95. Duchenne Muscular Dystrophy Key Opportunities and Drivers
Table 96. Duchenne Muscular Dystrophy Market Challenges
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Duchenne Muscular Dystrophy Product Picture
Figure 2. Global Duchenne Muscular Dystrophy Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Duchenne Muscular Dystrophy Market Share by Application in 2020 & 2026
Figure 6. Male Examples
Figure 7. Female Examples
Figure 8. Global Duchenne Muscular Dystrophy Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Duchenne Muscular Dystrophy Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Duchenne Muscular Dystrophy Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Duchenne Muscular Dystrophy Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Duchenne Muscular Dystrophy Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Duchenne Muscular Dystrophy Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Duchenne Muscular Dystrophy Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Duchenne Muscular Dystrophy Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Duchenne Muscular Dystrophy Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Duchenne Muscular Dystrophy Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Duchenne Muscular Dystrophy Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Duchenne Muscular Dystrophy Players Market Share by Revenue in Duchenne Muscular Dystrophy 2015 & 2019
Figure 26. Duchenne Muscular Dystrophy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Duchenne Muscular Dystrophy Revenue Share by Type (2015-2020)
Figure 28. Global Duchenne Muscular Dystrophy Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Duchenne Muscular Dystrophy Revenue Share by Application (2015-2020)
Figure 30. Global Duchenne Muscular Dystrophy Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Duchenne Muscular Dystrophy Sales Market Share by Type in 2019
Figure 32. United States Duchenne Muscular Dystrophy Sales Market Share by Type in 2019
Figure 33. Europe Duchenne Muscular Dystrophy Sales Market Share by Company in 2019
Figure 34. Europe Duchenne Muscular Dystrophy Sales Market Share by Type in 2019
Figure 35. Europe Duchenne Muscular Dystrophy Sales Market Share by Application in 2019
Figure 36. China Duchenne Muscular Dystrophy Sales Market Share by Company in 2019
Figure 37. China Duchenne Muscular Dystrophy Sales Market Share by Type in 2019
Figure 38. China Duchenne Muscular Dystrophy Sales Market Share by Application in 2019
Figure 39. Japan Duchenne Muscular Dystrophy Sales Market Share by Company in 2019
Figure 40. Japan Duchenne Muscular Dystrophy Sales Market Share by Type in 2019
Figure 41. Japan Duchenne Muscular Dystrophy Sales Market Share by Application in 2019
Figure 42. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Company in 2019
Figure 43. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Type in 2019
Figure 44. Southeast Asia Duchenne Muscular Dystrophy Sales Market Share by Application in 2019
Figure 45. India Duchenne Muscular Dystrophy Sales Market Share by Company in 2019
Figure 46. India Duchenne Muscular Dystrophy Sales Market Share by Type in 2019
Figure 47. India Duchenne Muscular Dystrophy Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Duchenne Muscular Dystrophy
Figure 50. Manufacturing Process Analysis of Duchenne Muscular Dystrophy
Figure 51. Duchenne Muscular Dystrophy Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
脊髄性筋萎縮症治療薬の世界市場レポート2020 Market Analysis and Insights: Global Spinal Muscular Atrophy Medicine Market The global Spinal Muscular Atrophy Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Spinal Muscular Atrophy Medicine Scope and Market …- インシュリン様成長因子IIの世界市場レポート2020 Market Analysis and Insights: Global Insulin Like Growth Factor II Market The global Insulin Like Growth Factor II market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Insulin Like Growth Factor II Scope and Market Size The …
- 解剖学的モデルの世界市場レポート2020 Anatomical models are a kind of models to study and explain the internal and external structure of the human body or animals as well as the various functions of the body's systems. Students interested in the medical profession as well as doctors, professors, and health care professionals profit from…
- 男性用グルーミング製品の世界市場レポート2020 Market Analysis and Insights: Global Male Grooming Product Market The global Male Grooming Product market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Male Grooming Product Scope and Market Size The global Male Grooming Pro…
- インテリジェントゲートコントロールの世界市場レポート2020 Market Analysis and Insights: Global Intelligent Gate-control Market The global Intelligent Gate-control market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Intelligent Gate-control Scope and Market Size The global Intellig…